chr16-87888119-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001739.2(CA5A):c.*10G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000451 in 1,592,760 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00065 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 0 hom. )
Consequence
CA5A
NM_001739.2 3_prime_UTR
NM_001739.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.150
Genes affected
CA5A (HGNC:1377): (carbonic anhydrase 5A) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA VA is localized in the mitochondria and expressed primarily in the liver. It may play an important role in ureagenesis and gluconeogenesis. CA5A gene maps to chromosome 16q24.3 and an unprocessed pseudogene has been assigned to 16p12-p11.2. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-87888119-C-T is Benign according to our data. Variant chr16-87888119-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3033707.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CA5A | NM_001739.2 | c.*10G>A | 3_prime_UTR_variant | 7/7 | ENST00000649794.3 | NP_001730.1 | ||
CA5A | NM_001367225.1 | c.774+3680G>A | intron_variant | NP_001354154.1 | ||||
CA5A | NR_159798.1 | n.1115G>A | non_coding_transcript_exon_variant | 8/8 | ||||
CA5A | NR_159799.1 | n.888G>A | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CA5A | ENST00000649794.3 | c.*10G>A | 3_prime_UTR_variant | 7/7 | NM_001739.2 | ENSP00000498065 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000651 AC: 99AN: 152188Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
99
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000478 AC: 115AN: 240812Hom.: 0 AF XY: 0.000529 AC XY: 69AN XY: 130392
GnomAD3 exomes
AF:
AC:
115
AN:
240812
Hom.:
AF XY:
AC XY:
69
AN XY:
130392
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000430 AC: 619AN: 1440454Hom.: 0 Cov.: 30 AF XY: 0.000433 AC XY: 309AN XY: 713992
GnomAD4 exome
AF:
AC:
619
AN:
1440454
Hom.:
Cov.:
30
AF XY:
AC XY:
309
AN XY:
713992
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000650 AC: 99AN: 152306Hom.: 1 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74464
GnomAD4 genome
AF:
AC:
99
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
36
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CA5A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 25, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at